Simple ultrasound may reveal hidden muscle loss after cancer
NCT ID NCT06007794
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether a quick ultrasound of the thigh muscle can detect muscle loss (sarcopenia) in people who have finished cancer treatment. Researchers will compare the ultrasound results with a standard whole-body scan (DEXA) in 55 adults aged 18-74 with certain cancers. The goal is to find a simpler way to identify muscle problems and connect patients with exercise or rehab programs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could provide a simpler, cheaper way to detect muscle loss in cancer survivors, helping guide rehabilitation.
What could go wrong
This is a small, early observational study (55 people) that only checks if ultrasound matches existing methods. It does not test any treatment, so it may not change care directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Lyon Sud, rhumatologie
RECRUITINGPierre-Bénite, 69495, France
Contact Phone: •••-•••-•••• Email: •••••@•••••